GlassScriptPhysician profile
Sarah B Valerio
NPI 1831561919
$75,880.17
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35K · 2022: $19K · 2023: $14K · 2024: $7,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $2,179 · Travel and Lodging: $237 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,927.50 |
| Food and Beverage | $2,178.65 |
| Travel and Lodging | $237.25 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66,341.16 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $4,470.45 | 2022 | |
| Allergan, INC. | $2,614.43 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $1,950.48 | 2021-2024 | Austedo Xr, Austedo, Ajovy |
| Biogen, INC. | $150.00 | 2023 | Tysabri |
| Biohaven Pharmaceuticals, INC. | $114.86 | 2021 | |
| Argenx US, INC. | $65.58 | 2024 | Vyvgart Hytrulo |
| Pfizer INC. | $48.49 | 2023-2024 | |
| Eisai INC. | $39.90 | 2024 | |
| Lilly USA, LLC | $29.33 | 2024 | Emgality, Reyvow |
| Lundbeck LLC | $23.68 | 2024 | Rexulti |
| Livanova USA, INC. | $16.60 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.21 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Valerio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.